Genetic Variants and Drug Efficacy in Tuberculosis: A Step toward Personalized Therapy.

Tuberculosis (TB) continues to be a major infectious disease affecting individuals worldwide. Current TB treatment strategy recommends the standard short-course chemotherapy regimen containing first-line drug, i.e.

Study on MICs of Tigecycline in Clinical Isolates of Carbapenem Resistant Enterobacteriaceae (CRE) at a Tertiary Care Centre in North India.

Introduction: Members of family are the most common Gram-negative bacteria isolated from clinical samples. Those which have acquired resistance to all β-lactams antibiotics including the carbapenems are considered as Carbapenem Resistant (CRE). These CRE isolates are often resistant to most other classes of antimicrobials as well, making their treatment a great challenge.